Suchergebnisse - "Petrone, Linda"

PubPharm (6)

1

Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases

enthalten in: Expert opinion on drug safety | 2020

von Cantini, F. | Blandizzi, C. | Niccoli, L. | +2

2

Systematic review on tuberculosis risk in patients with rheumatoid arthritis receiving inhibitors of Janus Kinases

enthalten in: Expert opinion on drug safety | 2020

von Cantini, F. | Blandizzi, C. | Niccoli, L. | +2

3

Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice

enthalten in: Expert opinion on drug safety | 2019

von Cantini, F. | Niccoli, L. | Capone, A. | +2

4

Risk of tuberculosis reactivation associated with traditional disease modifying anti-rheumatic drugs and non-anti-tumor necrosis factor biologics in patients with rheumatic disorders and suggestion for clinical practice

enthalten in: Expert opinion on drug safety | 2019

von Cantini, F. | Niccoli, L. | Capone, A. | +2

5

Evaluation of IP-10 in Quantiferon-Plus as biomarker for the diagnosis of latent tuberculosis infection

enthalten in: Tuberculosis (Edinburgh, Scotland) | 2018

von Petrone, L. | Vanini, V. | Chiacchio, T. | +6

6

Assessment of CD27 expression as a tool for active and latent tuberculosis diagnosis

enthalten in: The Journal of infection | 2015

von Petruccioli, E. | Petrone, L. | Vanini, V. | +6

1
[1]